共 15 条
[1]
Antithrombotic agents for secondary prevention after acute coronary syndromes: A systematic review and network meta-analysis[J] . Alexander C Fanaroff,Vic Hasselblad,Matthew T Roe,Deepak L Bhatt,Stefan K James,Ph Gabriel Steg,C Michael Gibson,E Magnus Ohman.International Journal of Cardiology . 2017
[2]
New Concepts and Mechanisms of Platelet Activation Signaling
[J].
PHYSIOLOGY,
2017, 32 (02)
:162-177
Estevez, Brian
;
Du, Xiaoping
.
[3]
The Molecular Mechanism of P2Y1 Receptor Activation
[J].
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION,
2016, 55 (35)
:10331-10335
Yuan, Shuguang
;
Chan, H. C. Stephen
;
Vogel, Horst
;
Filipek, Slawomir
;
Stevens, Raymond C.
;
Palczewski, Krzysztof
.
[4]
Platelet Activation: The Mechanisms and Potential Biomarkers[J] . Seong-Hoon Yun,Eun-Hye Sim,Ri-Young Goh,Joo-In Park,Jin-Yeong Han,Michele Cea.BioMed Research International . 2016
[5]
The platelet Fc receptor, FcγRIIa[J] . Jianlin Qiao,Mohammad Al‐Tamimi,Ross I. Baker,Robert K. Andrews,Elizabeth E. Gardiner.Immunol Rev . 2015 (1)
[6]
A novel snake venom‐derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury[J] . Ting‐Ting Li,Man‐Li Fan,Shi‐Xiang Hou,Xiao‐Yi Li,Devin M Barry,Hui Jin,Sheng‐Yong Luo,Feng Kong,Lit‐Fui Lau,Xiang‐Rong Dai,Guo‐Hui Zhang,Lan‐Lan Zhou.British Journal of Pharmacology . 2015 (15)
[7]
P2Y12 receptors: structure and function[J] . M. Cattaneo.J Thromb Haemost . 2015
[8]
Thromboxane Prostaglandin Receptor Antagonist and Carotid Atherosclerosis Progression in Patients With Cerebrovascular Disease of Ischemic Origin: A Randomized Controlled Trial[J] . Michiel L. Bots,Ian Ford,Suzanne M. Lloyd,Stephane Laurent,Pierre J. Touboul,Michael G. Hennerici.Stroke . 2014 (8)
[9]
Clopidogrel resistance: The way forward[J] . Shuvanan Ray.Indian Heart Journal . 2014
[10]
Cangrelor: a new CHAMPION for percutaneous coronary intervention[J] . Shamir R Mehta.The Lancet . 2013 (9909)